0.1426 USD
-0.02 (-10.82%)
0.11 USD
-0.03 (-22.86%)
Overall OMGA gets a fundamental rating of 2 out of 10. We evaluated OMGA against 525 industry peers in the Biotechnology industry. Both the profitability and financial health of OMGA have multiple concerns. OMGA is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- OMGA had negative earnings in the past year.
- In the past year OMGA has reported a negative cash flow from operations.
- OMGA had negative earnings in each of the past 5 years.
- In the past 5 years OMGA always reported negative operating cash flow.
1.2 Ratios
- OMGA has a Return On Assets (-47.86%) which is in line with its industry peers.
- OMGA has a Return On Equity of -633.21%. This is amonst the worse of the industry: OMGA underperforms 80.98% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -47.86% | ||
| ROE | -633.21% | ||
| ROIC | N/A |
ROA(3y)-49.09%
ROA(5y)-109.27%
ROE(3y)-99.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for OMGA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- OMGA does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, OMGA has more shares outstanding
- OMGA has a better debt/assets ratio than last year.
2.2 Solvency
- Based on the Altman-Z score of -4.95, we must say that OMGA is in the distress zone and has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of -4.95, OMGA is doing worse than 60.73% of the companies in the same industry.
- OMGA has a Debt/Equity ratio of 1.00. This is a high value indicating a heavy dependency on external financing.
- OMGA's Debt to Equity ratio of 1.00 is on the low side compared to the rest of the industry. OMGA is outperformed by 78.53% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -4.95 |
ROIC/WACCN/A
WACC9.59%
2.3 Liquidity
- OMGA has a Current Ratio of 1.61. This is a normal value and indicates that OMGA is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.61, OMGA is doing worse than 80.80% of the companies in the same industry.
- OMGA has a Quick Ratio of 1.61. This is a normal value and indicates that OMGA is financially healthy and should not expect problems in meeting its short term obligations.
- OMGA has a worse Quick ratio (1.61) than 79.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 1.61 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 36.06% over the past year.
- Looking at the last year, OMGA shows a very strong growth in Revenue. The Revenue has grown by 184.04%.
EPS 1Y (TTM)36.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)184.04%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%214.32%
3.2 Future
- The Earnings Per Share is expected to grow by 23.60% on average over the next years. This is a very strong growth
- OMGA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 150.92% yearly.
EPS Next Y34.35%
EPS Next 2Y24.8%
EPS Next 3Y20.55%
EPS Next 5Y23.6%
Revenue Next Year233.18%
Revenue Next 2Y29.68%
Revenue Next 3Y37.19%
Revenue Next 5Y150.92%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for OMGA. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OMGA. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as OMGA's earnings are expected to grow with 20.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.8%
EPS Next 3Y20.55%
5. Dividend
5.1 Amount
- No dividends for OMGA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
OMEGA THERAPEUTICS INC / OMGA FAQ
What is the ChartMill fundamental rating of OMEGA THERAPEUTICS INC (OMGA) stock?
ChartMill assigns a fundamental rating of 2 / 10 to OMGA.
What is the valuation status for OMGA stock?
ChartMill assigns a valuation rating of 1 / 10 to OMEGA THERAPEUTICS INC (OMGA). This can be considered as Overvalued.
What is the profitability of OMGA stock?
OMEGA THERAPEUTICS INC (OMGA) has a profitability rating of 0 / 10.
Can you provide the financial health for OMGA stock?
The financial health rating of OMEGA THERAPEUTICS INC (OMGA) is 1 / 10.
Can you provide the expected EPS growth for OMGA stock?
The Earnings per Share (EPS) of OMEGA THERAPEUTICS INC (OMGA) is expected to grow by 34.35% in the next year.